2762.3000 21.20 (0.77%)
NSE Sep 22, 2025 15:31 PM
Volume: 81,247
 

2762.30
0.77%
Karvy
Revenue growth lower than estimates: Revenues for the quarter at Rs 8821 mn were below our estimates of Rs 9469mn on account of lower traction.
GlaxoSmithKline Phar.. has an average target of 2800.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended